{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:26:23Z","timestamp":1774441583259,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010\/07020-9"],"award-info":[{"award-number":["2010\/07020-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/20341-0"],"award-info":[{"award-number":["2014\/20341-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["471885\/2013-4"],"award-info":[{"award-number":["471885\/2013-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-022-00778-2","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T10:05:39Z","timestamp":1662113139000},"page":"1952-1960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MicroRNA-149-3p expression correlates with outcomes of adrenocortical tumor patients and affects proliferation and cell cycle progression of H295A adrenocortical cancer cell line"],"prefix":"10.1007","volume":"35","author":[{"given":"Keteryne Rodrigues","family":"da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Chain","family":"Veronez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Alves Pereira","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gia Caroline Peixoto","family":"Lira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosane","family":"de Paula Silva Queiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonir Roberto Rauber","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Andres","family":"Yunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Regina","family":"Brandalise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Gonzaga","family":"Tone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6618-789X","authenticated-orcid":false,"given":"Carlos Alberto","family":"Scrideli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"issue":"1","key":"778_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jpedsurg.2015.10.039","volume":"51","author":"BC Gulack","year":"2016","unstructured":"Gulack BC, Rialon KL, Englum BR, et al. Factors associated with survival in pediatric adrenocortical carcinoma: an analysis of the National Cancer Data Base (NCDB). J Pediatr Surg. 2016;51(1):172\u20137. https:\/\/doi.org\/10.1016\/j.jpedsurg.2015.10.039.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"778_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","volume":"22","author":"E Michalkiewicz","year":"2004","unstructured":"Michalkiewicz E, Sandrini R, Figueiredo B, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004;22(5):838\u201345. https:\/\/doi.org\/10.1200\/JCO.2004.08.085.","journal-title":"J Clin Oncol"},{"issue":"1","key":"778_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1200\/JCO.1990.8.1.67","volume":"8","author":"RC Ribeiro","year":"1990","unstructured":"Ribeiro RC, Sandrini Neto RS, Schell MJ, Lacerda L, Sambaio GA, Cat I. Adrenocortical carcinoma in children: a study of 40 cases. J Clin Oncol. 1990;8(1):67\u201374. https:\/\/doi.org\/10.1200\/JCO.1990.8.1.67.","journal-title":"J Clin Oncol"},{"issue":"7","key":"778_CR4","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1210\/jcem.82.7.4057","volume":"82","author":"R Sandrini","year":"1997","unstructured":"Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab. 1997;82(7):2027\u201331. https:\/\/doi.org\/10.1210\/jcem.82.7.4057.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"778_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0929-693x(96)81300-5","volume":"3","author":"C Teinturier","year":"1996","unstructured":"Teinturier C, Brugi\u00e8res L, Lemerle J, Chaussain JL, Bougn\u00e8res PF. Adrenocortical carcinoma in children: retrospective study of 54 cases. Arch Pediatr. 1996;3(3):235\u201340. https:\/\/doi.org\/10.1016\/0929-693x(96)81300-5.","journal-title":"Arch Pediatr"},{"issue":"1","key":"778_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2011.10.019","volume":"351","author":"G Cust\u00f3dio","year":"2012","unstructured":"Cust\u00f3dio G, Komechen H, Figueiredo FR, Fachin ND, Pianovski MA, Figueiredo BC. Molecular epidemiology of adrenocortical tumors in southern Brazil. Mol Cell Endocrinol. 2012;351(1):44\u201351. https:\/\/doi.org\/10.1016\/j.mce.2011.10.019.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"778_CR7","first-page":"305","volume":"3","author":"CA Stiller","year":"1994","unstructured":"Stiller CA. International variations in the incidence of childhood carcinomas. Cancer Epidemiol Biomarkers Prev. 1994;3(4):305\u201310.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"778_CR8","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1210\/jcem.86.10.7957","volume":"86","author":"AC Latronico","year":"2001","unstructured":"Latronico AC, Pinto EM, Domenice S, et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab. 2001;86(10):4970\u20133. https:\/\/doi.org\/10.1210\/jcem.86.10.7957.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"778_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1590\/s0004-27302004000500009","volume":"48","author":"EM Pinto","year":"2004","unstructured":"Pinto EM, Billerbeck AE, Villares MC, Domenice S, Mendon\u00e7a BB, Latronico AC. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arq Bras Endocrinol Metabol. 2004;48(5):647\u201350. https:\/\/doi.org\/10.1590\/s0004-27302004000500009.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"778_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/pbc.20318","volume":"45","author":"C Rodriguez-Galindo","year":"2005","unstructured":"Rodriguez-Galindo C, Figueiredo BC, Zambetti GP, Ribeiro RC. Biology, clinical characteristics, and management of adrenocortical tumors in children. Pediatr Blood Cancer. 2005;45(3):265\u201373. https:\/\/doi.org\/10.1002\/pbc.20318.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"778_CR11","doi-asserted-by":"publisher","first-page":"101448","DOI":"10.1016\/j.beem.2020.101448","volume":"34","author":"EM Pinto","year":"2020","unstructured":"Pinto EM, Zambetti GP, Rodriguez-Galindo C. Pediatric adrenocortical tumours. Best Pract Res Clin Endocrinol Metab. 2020;34(3):101448. https:\/\/doi.org\/10.1016\/j.beem.2020.101448.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"778_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/MED.0000000000000540","volume":"27","author":"VB Brondani","year":"2020","unstructured":"Brondani VB, Fragoso MCBV. Pediatric adrenocortical tumor - review and management update. Curr Opin Endocrinol Diabetes Obes. 2020;27(3):177\u201386. https:\/\/doi.org\/10.1097\/MED.0000000000000540.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"11","key":"778_CR13","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1158\/0008-5472.CAN-09-3970","volume":"70","author":"M Doghman","year":"2010","unstructured":"Doghman M, El Wakil A, Cardinaud B, et al. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res. 2010;70(11):4666\u201375. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3970.","journal-title":"Cancer Res"},{"issue":"30","key":"778_CR14","doi-asserted-by":"publisher","first-page":"49191","DOI":"10.18632\/oncotarget.16788","volume":"8","author":"\u0141 Koperski","year":"2017","unstructured":"Koperski \u0141, Kotlarek M, \u015awierniak M, et al. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy. Oncotarget. 2017;8(30):49191\u2013200. https:\/\/doi.org\/10.18632\/oncotarget.16788.","journal-title":"Oncotarget"},{"key":"778_CR15","doi-asserted-by":"publisher","first-page":"e29553","DOI":"10.1002\/pbc.29553","volume":"69","author":"LC Veronez","year":"2022","unstructured":"Veronez LC, Fedatto PF, Correa CAP, et al. MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors. Pediatr Blood Cancer. 2022;69:e29553. https:\/\/doi.org\/10.1002\/pbc.29553.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"778_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","volume":"122","author":"CM Croce","year":"2005","unstructured":"Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005;122(1):6\u20137. https:\/\/doi.org\/10.1016\/j.cell.2005.06.036.","journal-title":"Cell"},{"issue":"6","key":"778_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/jor.21055","volume":"28","author":"Z Duan","year":"2010","unstructured":"Duan Z, Choy E, Nielsen GP, et al. Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res. 2010;28(6):746\u201352. https:\/\/doi.org\/10.1002\/jor.21055.","journal-title":"J Orthop Res"},{"issue":"2","key":"778_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002.","journal-title":"Cell"},{"issue":"5","key":"778_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/1389201015666140519095304","volume":"15","author":"L Tutar","year":"2014","unstructured":"Tutar L, Tutar E, Tutar Y. MicroRNAs and cancer; an overview. Curr Pharm Biotechnol. 2014;15(5):430\u20137. https:\/\/doi.org\/10.2174\/1389201015666140519095304.","journal-title":"Curr Pharm Biotechnol"},{"key":"778_CR20","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4.","journal-title":"Signal Transduct Target Ther"},{"issue":"44","key":"778_CR21","doi-asserted-by":"publisher","first-page":"71960","DOI":"10.18632\/oncotarget.12443","volume":"7","author":"D Cao","year":"2016","unstructured":"Cao D, Jia Z, You L, et al. 18\u03b2-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling. Oncotarget. 2016;7(44):71960\u201373. https:\/\/doi.org\/10.18632\/oncotarget.12443.","journal-title":"Oncotarget"},{"issue":"6","key":"778_CR22","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.3892\/mmr.2016.5205","volume":"13","author":"L Jin","year":"2016","unstructured":"Jin L, Li Y, Liu J, et al. Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. Mol Med Rep. 2016;13(6):5386\u201392. https:\/\/doi.org\/10.3892\/mmr.2016.5205.","journal-title":"Mol Med Rep"},{"issue":"9","key":"778_CR23","doi-asserted-by":"publisher","first-page":"12339","DOI":"10.1007\/s13277-016-5106-y","volume":"37","author":"L Lin","year":"2016","unstructured":"Lin L, Zhang YD, Chen ZY, Chen Y, Ren CP. The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo\/radiotherapy. Tumour Biol. 2016;37(9):12339\u201346. https:\/\/doi.org\/10.1007\/s13277-016-5106-y.","journal-title":"Tumour Biol"},{"issue":"7","key":"778_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bph.13718","volume":"174","author":"L Si","year":"2017","unstructured":"Si L, Xu L, Yin L, et al. Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway. Br J Pharmacol. 2017;174(7):553\u201368. https:\/\/doi.org\/10.1111\/bph.13718.","journal-title":"Br J Pharmacol"},{"key":"778_CR25","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.12659\/msm.899114","volume":"22","author":"P Tian","year":"2016","unstructured":"Tian P, Yan L. Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG). Med Sci Monit. 2016;22:5116\u201323. https:\/\/doi.org\/10.12659\/msm.899114.","journal-title":"Med Sci Monit"},{"issue":"11","key":"778_CR26","first-page":"2209","volume":"7","author":"D Yang","year":"2017","unstructured":"Yang D, Du G, Xu A, Xi X, Li D. Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4. Am J Cancer Res. 2017;7(11):2209\u201319.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"778_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cas.13161","volume":"108","author":"G Zhang","year":"2017","unstructured":"Zhang G, Liu X, Li Y, et al. EphB3-targeted regulation of miR-149 in the migration and invasion of human colonic carcinoma HCT116 and SW620 cells. Cancer Sci. 2017;108(3):408\u201318. https:\/\/doi.org\/10.1111\/cas.13161.","journal-title":"Cancer Sci"},{"issue":"7043","key":"778_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834\u20138. https:\/\/doi.org\/10.1038\/nature03702.","journal-title":"Nature"},{"key":"778_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.compbiomed.2016.11.008","volume":"80","author":"Y Piao","year":"2017","unstructured":"Piao Y, Piao M, Ryu KH. Multiclass cancer classification using a feature subset-based ensemble from microRNA expression profiles. Comput Biol Med. 2017;80:39\u201344. https:\/\/doi.org\/10.1016\/j.compbiomed.2016.11.008.","journal-title":"Comput Biol Med"},{"issue":"4","key":"778_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1530\/ERC-13-0051","volume":"20","author":"O Chabre","year":"2013","unstructured":"Chabre O, Lib\u00e9 R, Assie G, et al. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocr Relat Cancer. 2013;20(4):579\u201394. https:\/\/doi.org\/10.1530\/ERC-13-0051.","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"778_CR31","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.humpath.2014.04.005","volume":"45","author":"E Duregon","year":"2014","unstructured":"Duregon E, Rapa I, Votta A, et al. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations. Hum Pathol. 2014;45(8):1555\u201362. https:\/\/doi.org\/10.1016\/j.humpath.2014.04.005.","journal-title":"Hum Pathol"},{"issue":"34","key":"778_CR32","doi-asserted-by":"publisher","first-page":"36675","DOI":"10.18632\/oncotarget.5383","volume":"6","author":"AR Glover","year":"2015","unstructured":"Glover AR, Zhao JT, Gill AJ, et al. MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma. Oncotarget. 2015;6(34):36675\u201388. https:\/\/doi.org\/10.18632\/oncotarget.5383.","journal-title":"Oncotarget"},{"issue":"8","key":"778_CR33","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/cncr.25724","volume":"117","author":"EE Patterson","year":"2011","unstructured":"Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer. 2011;117(8):1630\u20139. https:\/\/doi.org\/10.1002\/cncr.25724.","journal-title":"Cancer"},{"issue":"3","key":"778_CR34","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1677\/ERC-09-0096","volume":"16","author":"Z T\u00f6mb\u00f6l","year":"2009","unstructured":"T\u00f6mb\u00f6l Z, Szab\u00f3 PM, Moln\u00e1r V, et al. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer. 2009;16(3):895\u2013906. https:\/\/doi.org\/10.1677\/ERC-09-0096.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"778_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1530\/ERC-11-0082","volume":"18","author":"DM \u00d6zata","year":"2011","unstructured":"\u00d6zata DM, Caramuta S, Vel\u00e1zquez-Fern\u00e1ndez D, et al. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer. 2011;18(6):643\u201355. https:\/\/doi.org\/10.1530\/ERC-11-0082.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"778_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13048-021-00919-5","volume":"14","author":"J Wang","year":"2021","unstructured":"Wang J, Liu L. MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A. J Ovarian Res. 2021;14(1):165. https:\/\/doi.org\/10.1186\/s13048-021-00919-5.","journal-title":"J Ovarian Res"},{"key":"778_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12935-019-0742-0","volume":"19","author":"MH Ma","year":"2019","unstructured":"Ma MH, An JX, Zhang C, et al. ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression. Cancer Cell Int. 2019;19:27. https:\/\/doi.org\/10.1186\/s12935-019-0742-0.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"778_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3892\/mmr.2020.11811","volume":"23","author":"Q Shen","year":"2021","unstructured":"Shen Q, Zhu H, Lei Q, Chen L, Yang D, Sui W. MicroRNA-149-3p inhibits cell proliferation by targeting AKT2 in oral squamous cell carcinoma. Mol Med Rep. 2021;23(3):172. https:\/\/doi.org\/10.3892\/mmr.2020.11811.","journal-title":"Mol Med Rep"},{"key":"778_CR39","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.2147\/OTT.S222380","volume":"12","author":"J Yao","year":"2019","unstructured":"Yao J, Wu X. Upregulation of miR-149-3p suppresses spinal chordoma malignancy by targeting smad3. Onco Targets Ther. 2019;12:9987\u201397. https:\/\/doi.org\/10.2147\/OTT.S222380.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"778_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-2007-993164","volume":"116","author":"A Babinska","year":"2008","unstructured":"Babinska A, Sworczak K, Wisniewski P, Na\u0142ecz A, Jaskiewicz K. The role of immunohistochemistry in histopathological diagnostics of clinically \u201csilent\u201d incidentally detected adrenal masses. Exp Clin Endocrinol Diabetes. 2008;116(4):246\u201351. https:\/\/doi.org\/10.1055\/s-2007-993164.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"8","key":"778_CR41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/01.MP.0000081730.72305.81","volume":"16","author":"A Stojadinovic","year":"2003","unstructured":"Stojadinovic A, Brennan MF, Hoos A, et al. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis. Mod Pathol. 2003;16(8):742\u201351. https:\/\/doi.org\/10.1097\/01.MP.0000081730.72305.81.","journal-title":"Mod Pathol"},{"issue":"12","key":"778_CR42","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1128\/MCB.16.12.6623","volume":"16","author":"PD Adams","year":"1996","unstructured":"Adams PD, Sellers WR, Sharma SK, Wu AD, Nalin CM, Kaelin WG. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol. 1996;16(12):6623\u201333. https:\/\/doi.org\/10.1128\/MCB.16.12.6623.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"778_CR43","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/s0955-0674(96)80081-0","volume":"8","author":"J Bartek","year":"1996","unstructured":"Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol. 1996;8(6):805\u201314. https:\/\/doi.org\/10.1016\/s0955-0674(96)80081-0.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"778_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/CCO.0b013e32835b639e","volume":"25","author":"NA Warfel","year":"2013","unstructured":"Warfel NA, El-Deiry WS. p21WAF1 and tumourigenesis: 20 years after. Curr Opin Oncol. 2013;25(1):52\u20138. https:\/\/doi.org\/10.1097\/CCO.0b013e32835b639e.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"778_CR45","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/EJE-17-0976","volume":"179","author":"SS Pereira","year":"2018","unstructured":"Pereira SS, Monteiro MP, Bourdeau I, Lacroix A, Pignatelli D. Mechanisms of endocrinology: Cell cycle regulation in adrenocortical carcinoma. Eur J Endocrinol. 2018;179(2):R95\u2013110. https:\/\/doi.org\/10.1530\/EJE-17-0976.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"778_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","volume":"46","author":"G Assi\u00e9","year":"2014","unstructured":"Assi\u00e9 G, Letouz\u00e9 E, Fassnacht M, et al. Integrated genomic characterization of adrenocortical carcinoma. Nat Genet. 2014;46(6):607\u201312. https:\/\/doi.org\/10.1038\/ng.2953.","journal-title":"Nat Genet"},{"issue":"5","key":"778_CR47","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","volume":"29","author":"S Zheng","year":"2016","unstructured":"Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016;29(5):723\u201336. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.002.","journal-title":"Cancer Cell"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-022-00778-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-022-00778-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-022-00778-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T20:08:59Z","timestamp":1664309339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-022-00778-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s13577-022-00778-2","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Ethics Committees of Ribeir\u00e3o Preto Medical School and Boldrini Children\u2019s Center (protocol numbers 8380\/2010 and 1.75\u2013050,809, respectively).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}